Abstract:A low‐toxic aggregate of manganese‐based polyoxometalate single‐atom enzyme (Mn‐POM SAE) is constructed at neutral conditions. Specifically, Mn‐POM SAE nanospheres exhibit acid‐triggered nontoxicity‐to‐toxicity transition in acid tumor microenvironment (TME), upon degradation of larger Mn‐POM SAE into smaller toxic units of Mn(II)‐PW11. Therefore, the multienzyme‐mimicking (POD‐, OXD‐, CAT‐, and Gpx‐like) activity is initiated through single/double electron transfers for efficient and specific therapy. Single‐atom enzymes (SAzymes) exhibit great potential for chemodynamic therapy (CDT); while, general application is still challenged by their instability and unavoidable side effects during delivery. Herein, a manganese‐based polyoxometalate single‐atom enzyme (Mn‐POM SAE) is first introduced into tumor‐specific CDT, which exhibits tumor microenvironment (TME)‐activated transition of nontoxicity‐to‐toxicity. Different from traditional POM materials, the aggregates of low‐toxic Mn‐POM SAE nanospheres are obtained at neutral conditions, facilitating efficient delivery and avoiding toxicity problems in normal tissues. Under acid TME conditions, these nanospheres are degraded into smaller units of toxic Mn(II)‐PW11; thus, initiating cancer cell‐specific therapy. The released active units of Mn(II)‐PW11 exhibit excellent multienzyme‐like activities (including peroxidase (POD)‐like, oxidase (OXD)‐like, catalase (CAT)‐like, and glutathione peroxidase (Gpx)‐like activities) for the synergistic cancer therapy due to the stabilized high valence Mn species (MnIII/MnIV). As demonstrated by both intracellular evaluations and in vivo experiments, ROS is generated to cause damage to lysosome membranes, further facilitating acidification and impaired autophagy to enhance cancer therapy. This study provides a detailed investigation on the acid‐triggered releasing of active units and the electron transfer in multienzyme‐mimic‐like therapy, further enlarging the application of POMs from catalytical engineering into cancer therapy.

Lindqvist-type Polyoxometalates Act as Anti-breast Cancer Drugs via Mitophagy-induced Apoptosis

Tris‐functionalized polyoxotungstovanadate‐mediated antitumor efficacy involves multiple cell death pathways

Polyoxometalates Nanoparticles Improve Anti-Tumor Activity by Maximal Cellular Uptake

Antitumor Effects of a Sb-rich Polyoxometalate on Non-Small-Cell Lung Cancer by Inducing Ferroptosis and Apoptosis

Polyoxometalates Immobilized on MIL-100 (fe) As an Emerging Platform for Eliminating Breast Cancer Tumor Cells

Anticancer Polyoxometalates

Polyoxometalate-Based Organic-Inorganic Hybrids as Antitumor Drugs.

Polyoxometalate-biomolecule Conjugates: a New Approach to Create Hybrid Drugs for Cancer Therapeutics.

Synthesis, Cytotoxicity and Antitumour Mechanism Investigations of Polyoxometalate Doped Silica Nanospheres on Breast Cancer MCF-7 Cells.

Enhanced antitumor activity of polyoxometalates loaded solid lipid nanoparticles

Polyoxometalate Modified by Zeolite Imidazole Framework for the Ph-Responsive Electrodynamic/Chemodynamic Therapy

Combinatorial discovery of Mo-based polyoxometalate clusters for tumor photothermal therapy and normal cell protection

Promising Application of Polyoxometalates in the Treatment of Cancer, Infectious Diseases and Alzheimer’s Disease

Research Progress on Antitumor Effect of Polyoxometalates

Promising application of polyoxometalates in the treatment of cancer, infectious diseases and Alzheimer's disease

Ni/Mn-Complex-Tethered Tetranuclear Polyoxovanadates: Crystal Structure and Inhibitory Activity on Human Hepatocellular Carcinoma (HepG-2)

Degradable Organically-Derivatized Polyoxometalate with Enhanced Activity Against Glioblastoma Cell Line.

Hetero-bimetallic Transition Metal-Substituted Krebs-type Polyoxometalate with N-chelating Ligand As Anticancer Agents

Multienzyme‐Like Polyoxometalate‐Based Single‐Atom Enzymes for Cancer‐Specific Therapy Through Acid‐Triggered Nontoxicity‐to‐Toxicity Transition

The Anti-Proliferation Activity And Mechanism Of Action Of K-12[V18o42(H2o)]Center Dot 6h(2)O On Breast Cancer Cell Lines

The Anti-Proliferation Activity and Mechanism of Action of K 12 [V 18 O 42 (H₂O)]∙6H₂O on Breast Cancer Cell Lines.